Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide

Journal of Investigative Dermatology

Volumn 114, Issue 1, 2000, Pages 34-39

  Rünger, Thomas M ^a,b,e   Emmert, Steffen ^a   Schadendorf, Dirk ^c   Diem, Caroline ^b   Epe, Bernd ^d   Hellfritsch, Doris ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Base excision repair; Chemoresistance; Mismatch repair; Nucleotide excision repair

Indexed keywords

CISPLATIN; ETOPOSIDE; FOTEMUSTINE; VINDESINE;

ALKYLATION; ANIMAL CELL; ARTICLE; CELL INTERACTION; CELL PROTECTION; CROSS LINKING; DNA REPAIR; EXCISION REPAIR; GENE EXPRESSION REGULATION; MELANOMA CELL; MICROSATELLITE INSTABILITY; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0034075593     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00844.x     Document Type: Article

References (34)

1. Dabholkar M, Reed E: Host cell reactivation of cisplatin-damaged plasmid DNA in human non-T leukocyte cell lines. Cancer Lett 63:143-150, 1992
2. Diem C, Rünger TM: A novel plasmid shuttle vector for the detection and analysis of microsatellite instability in cell lines. Mutat Res 407:117-124, 1998
3. Eastman A: An improvement to the novel rapid assay for chloramphenical acetyltransferase gene expression. Biotechniques 5:730-732, 1999
4. Fink D, Aebi S, Howell SB: The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4:1-6, 1998a
5. Fink D, Nebel S, Norris PS, Aebi S, Kim HK, Haas M, Howell SB: The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells. Br J Cancer 77:703-708, 1998b
6. Friedberg EC, Walker GC, Siede W (eds): DNA Repair and Mutagenesis Washington: ASM Press, 1995
7. Gerson SL, Trey JE: Modulation of nitrosourea resistance in myeloid leukemias. Blood 71:1487-1494, 1988
8. Grösch S, Fritz G, Kaina B: Apurinic endonuclease (ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation. Cancer Res 58:4410-4416, 1998
9. Harris AL: DNA repair and resistance to chemotherapy. Cancer Surv 4:601-624, 1985
10. Hatton DH, Mitchell DL, Strickland PT, Johnson RT: Enhanced photoproduct repair: its role in the DNA damage-resistance phenotype of human malignant melanoma cells. Cancer Res 55:181-189, 1995
11. Henwood JM, Brogden RN: Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer. Drugs 39:438-490, 1990
12. Hill BT, Shellard SA, Fichtinger Schepman AM, Schmoll HJ, Harstrick A: Differential formation and enhanced removal of specific cisplatin-DNA adducts in two cisplatin-selected resistant human testicular teratoma sublines. Anticancer Drugs 5:321-328, 1994
13. Johnson SW, Swiggard PA, Handel LM, Brennan JM, Godwin AK, Ozols RF, Hamilton TC: Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells. Cancer Res 54:5911-5916, 1994
14. Karran P, Hampson R: Genomic instability' and tolerance to alkylating agents. Cancer Surv 28:69-85, 1996
15. Kern MA, Helmbach H, Artuc M, Karmann D, Jurgowsky K, Schadendorf D: Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. Anticancer Res 17:4359-4370, 1997
16. Koberle B, Masters JR, Hartley JA, Wood RD: Defective repair of cisplatin-induced DNA, damage caused by reduced XPA: protein in testicular germ cell tumours. Curr Biol 9:273-276, 1999
17. 6-benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Chemother Pharmacol 39:307-316, 1997
18. Lage H, Christmann M, Kern MA, Dietel M, Pick M, Kaina B, Schadendorf D: Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, MGMT and MPT in melanoma cells with acquired drug resistance. Int J Cancer 80:744-750, 1999
19. Ludlum DB: The chloroethylnitrosoureas: sensitivity and resistance to cancer chemotherapy at the molecular level. Cancer Invest 15:588-598, 1997
20. Masuda H, Ozols RF, Lai GM, Fojo A, Rothenberg M, Hamilton TC: Increased DNA repair as a mechanism of acquired resistance to cisdiarninedichloroplatinum(II) in human ovarian cancer cell lines. Cancer Res 48:5713-5716, 1988
21. Maynard KR, Hosking LK, Hill BT: Use of host cell reactivation of cisplatin-treated adenovirus 5 in human cell lines to detect repair of drug-treated DNA. Chem Biol Interact 71:353-365, 1989
22. Maze R, Carney JP, Kelley MR, Glassner BJ, Williams DA, Samson L: Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent. Proc Natl Acad Sci USA 93:206-210, 1996
23. McKeage MJ, Higgins JD, Kelland LR: Platinum and other metal coordination compounds in cancer chemotherapy. A commentary on the sixth international symposium: San Diego, California, 23-26th January 1991. Br J Cancer 64:788-792, 1991
24. Müller E, Boiteux S, Cunningham RP, Epe B: Enzymatic recognition of DNA modifications induced by singlet oxygen and photosensitizers. Nucl Acids Res 18:5969-5973, 1990
25. Neumann JR, Morency CA, Russian KO; A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5:444-447, 1987
26. 6-alkylguanine, FASEB J 6:2302-2310, 1992
27. Radicella JP, Dherin C, Desmaze C, Fox MS, Boiteux S: Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 94:8010-8015, 1997
28. Rünger TM, Epe B, Möller K: Repair of ultraviolet B and singlet oxygen-induced DNA damage in xeroderma pigmentosum cells. J Invest Dermatol 104:68-73, 1995
29. Seidman MM, Dixon K, Razzaque A, Zagursky RJ, Herman ML: A shuttle vector plasmid for studying carcinogen-induced point mutations in mammalian cells. Gene 38:233-237, 1985
30. Vilpo JA, Vilpo LM, Szymkowski DE, O'Donovan A, Wood RD: An XPG DNA repair defect causing mutagen hypersensitivity in mouse leukemia L1210 cells. Mol Cell Biol 15:290-297, 1995
31. 6-alkylguanme-DNA alkyltransferase activity. Br J Cancer 74:1030-1036, 1996
32. 6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model. Cancer Chemother Pharmacol 40:266-272, 1997
33. Wei Q, Cheng L, Xie K, Bucana CD, Dong Z: Direct correlation between DNA repair capacity and metastatic potential of K-1735 murine melanoma cells. J Invest Dermatol 108:3-6, 1997
34. Zeng Rong N, Paterson J, Alpert L, Tsao MS, Viallet J, Alaoui-Jamali MA: Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy. Cancer Res 55:4760-4764, 1995